 Home > Medical News > Medical Research Articles > Chuangsheng Group announces that its humanized anti-VEGFR-2 monoclonal antibody MSB0254 Phase Ib clinical trial has completed the first patient administration

Chuangsheng Group announces that its humanized anti-VEGFR-2 monoclonal antibody MSB0254 Phase Ib clinical trial has completed the first patient administration

 Last Update: 2022-01-03
 Source: Internet
 Author: User

Tags

mrna cancer treatment

black li

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Suzhou, November 25, 2021/PRNewswire/ - Chuangsheng Group (06628.

This study aims to evaluate the safety, tolerability, PK characteristics and anti-tumor efficacy of MSB0254 in a variety of solid tumors, including neuroendocrine tumors and hepatocellular carcinoma, at the recommended doses of phase II clinical trials

MSB0254 is a high-affinity humanized anti-VEGFR-2 monoclonal antibody with an anti-tumor mechanism that inhibits tumor angiogenesis.

About MSB0254

About Chuangsheng Group

Chuangsheng Group is headquartered in Suzhou and has successfully established a global business layout: it has a drug discovery, clinical and translational research center in Suzhou, a process and product development center and a drug production base in Hangzhou, and in Beijing, Shanghai, Guangzhou and the United States Princeton has established clinical development centers, and established foreign cooperation centers in Boston and Los Angeles

For more information about Transcenta Group, please visit the company's website:or LinkedIn account: Transcenta

Forward-looking statements

These forward-looking statements are based on the current views, assumptions, expectations, estimates, forecasts and understandings of the company’s management regarding future affairs at the time the statement was made

For more information, please contact

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.